Login / Signup

Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial.

Gilles DeferSophie FedrizziDamien ChevanneFrançois MontastrucAnais R BriantJean-Jacques ParientiLaure Peyro-Saint-Paulnull nullnull null
Published in: Drug safety (2020)
NCT03029897, registered in 2017.
Keyphrases
  • adverse drug
  • multiple sclerosis
  • electronic health record
  • study protocol
  • emergency department
  • white matter
  • randomized controlled trial